XHKG
6699
Market cap1.56bUSD
Jul 10, Last price
73.40HKD
1D
2.66%
1Q
-11.30%
IPO
-80.68%
Name
Angelalign Technology Inc
Chart & Performance
P/E
54.54
P/S
4.19
EPS
1.17
Div Yield, %
1.17%
Shrs. gr., 5y
0.38%
Rev. gr., 5y
26.00%
Revenues
2.59b
+32.16%
Net income
199m
+125.21%
CFO
712m
+4,109.18%
Dividend
Sep 04, 20250.46 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Angelalign Technology Inc. functions as an investment holding enterprise primarily dedicated to the innovation, production, and distribution of clear aligner solutions for orthodontic treatment throughout China. Their key offerings, Angel Aligner Pro and Angel Aligner Classic, are bespoke, removable clear aligners designed to gradually guide a patient's teeth into proper alignment over time. Beyond aligner development, the company also operates dental clinics that provide a variety of services, including orthodontics and cosmetic dentistry, and distributes intraoral scanners. Their extensive portfolio of clear aligner brands features Angelalign, Angelalign Pro, Angelalign Kid, and COMFOS. The firm was founded in 2003 and maintains its principal offices in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||